Keyphrases
Mouse Model
100%
Glucose Transporter 4 (GLUT4)
100%
Dilated Cardiomyopathy
100%
Acute Decompensated Heart Failure
100%
HIV Protease Inhibitors
100%
Ritonavir
60%
Atazanavir
60%
Glucose Transport
40%
Lopinavir
40%
Glucose Homeostasis
20%
Insulin Resistance
20%
Overexpression
20%
Transgenic Mouse Model
20%
Cardiovascular Risk
20%
Non-transgenic
20%
Cre Recombinase
20%
Cardiomyopathy
20%
Heart Failure
20%
Clinical Application
20%
Drug Exposure
20%
Metabolic Changes
20%
Echocardiography
20%
Drug Administration
20%
Cardiac Function
20%
Intraperitoneal Injection
20%
Failing Heart
20%
Human Patients
20%
Impaired Glucose Tolerance
20%
Pulmonary Edema
20%
Myocardial Glucose Uptake
20%
Littermate Controls
20%
Glucose Tolerance Test
20%
2-Deoxyglucose Uptake
20%
Medicine and Dentistry
Acute Decompensated Heart Failure
100%
Dilated Cardiomyopathy
100%
Human Immunodeficiency Virus Proteinase Inhibitor
100%
Glucose Transporter 4
100%
Glucose Uptake
60%
Ritonavir
40%
Lopinavir/Ritonavir
40%
Atazanavir
40%
Insulin Resistance
20%
Cre Recombinase
20%
Echocardiography
20%
Congestive Heart Failure
20%
Heart Death
20%
Glucose Tolerance
20%
Drug Administration
20%
Intraperitoneal Drug Administration
20%
Heart Function
20%
Cardiovascular Risk
20%
Pulmonary Edema
20%
Glucose Homeostasis
20%
Myocardial Disease
20%
Deoxyglucose
20%
Impaired Glucose Tolerance
20%
Drug Exposure
20%
Lopinavir
20%
Atazanavir Plus Ritonavir
20%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Glucose Transporter 4
100%
Acute Heart Failure
100%
Congestive Cardiomyopathy
100%
Human Immunodeficiency Virus Proteinase Inhibitor
100%
Ritonavir
40%
Atazanavir
40%
Lopinavir Plus Ritonavir
40%
Insulin Resistance
20%
Congestive Heart Failure
20%
Deoxyglucose
20%
Drug Administration
20%
Cardiovascular Risk
20%
Lung Edema
20%
Impaired Glucose Tolerance
20%
Transgenic Organism
20%
Heart Death
20%
Myocardial Disease
20%
Intraperitoneal Injection
20%
Cre Recombinase
20%
Atazanavir Plus Ritonavir
20%
Lopinavir
20%